STRATA Skin Sciences, Inc. (SSKN) EBT Margin (2012 - 2025)
STRATA Skin Sciences (SSKN) posted EBT Margin of 2.35% for Q4 2025, up 110.01% sequentially from 23.44% in Q3 2025, and up 5029.0% YoY from 0.05% in Q4 2024.
STRATA Skin Sciences, Inc. (SSKN) EBT Margin (2012 - 2025) Analysis & Trends
STRATA Skin Sciences has reported EBT Margin for 14 years, with the latest figure at 2.35% in Q4 2025.
- Quarterly EBT Margin rose 5029.0% year-over-year to 2.35% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 23.04% (up 969.0% YoY) and the FY2025 annual result came in at 20.2%, up 1036.0% from the prior year.
- EBT Margin grew to 2.35% in Q4 2025 per SSKN's latest filing, from 23.44% in the prior quarter.
- Over five years, EBT Margin peaked at 14.71% in Q2 2021 and troughed at 49.84% in Q1 2024.
- A 5-year average of 23.14% and a median of 23.51% in 2024 frame the typical range for EBT Margin.
- The sharpest annual moves came in 2021 and 2023: EBT Margin surged 5523 bps in 2021, then tumbled 4381 bps in 2023.
- Over 5 years, EBT Margin stood at 9.13% in 2021, then soared by 90 bps to 0.91% in 2022, then tumbled by 4788 bps to 44.72% in 2023, then fell by 7 bps to 47.94% in 2024, then jumped by 105 bps to 2.35% in 2025.
- According to Business Quant data, EBT Margin over the past three periods registered 2.35%, 23.44%, and 45.27% for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.35% |
| Sep 30, 2025 | -23.44% |
| Jun 30, 2025 | -45.27% |
| Mar 31, 2025 | -32.25% |
| Dec 31, 2024 | -47.94% |
| Sep 30, 2024 | -23.58% |
| Jun 30, 2024 | -11.32% |
| Mar 31, 2024 | -49.84% |
| Dec 31, 2023 | -44.72% |
| Sep 30, 2023 | -11.90% |
| Jun 30, 2023 | -27.14% |
| Mar 31, 2023 | -37.47% |
| Dec 31, 2022 | -0.91% |
| Sep 30, 2022 | -10.57% |
| Jun 30, 2022 | -20.78% |
| Mar 31, 2022 | -35.53% |
| Dec 31, 2021 | -9.13% |
| Sep 30, 2021 | -6.70% |
| Jun 30, 2021 | 14.71% |
| Mar 31, 2021 | -41.43% |